No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

Monoclonal antibodies (mAbs) and immune checkpoint inhibitors are two types of immunotherapy ... All contributions to this Research Topic must be within the scope of the section and journal to which ...

Despite its vital role in "kick-starting" the immune response, IgD is arguably the least understood antibody, with little known about how it might participate in other parts of the immune system. A ...

Antibodies can be classified into two types: monoclonal and polyclonal. Monoclonal antibodies have specificity for a particular antigen (target of antibodies), but polyclonal ones are not specific ...

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria. A novel class of antibodies that binds to ...

Antibody therapies are a type of biologic. They are typically monoclonal antibodies selected to bind to a particular protein (often a cell-surface protein), and produced using recombinant DNA ...

The FDA has granted Priority Review to nipocalimab for the treatment of antibody positive patients with generalized myasthenia gravis.

Therefore, an in-depth understanding of structures of enterovirus and mechanisms of antibody neutralization should be useful for future strategies in guiding the design of a rational antiviral agent ...

s Inmazeb (consisting of the monoclonal antibodies atoltivimab, maftivimab, and odesivimab-ebgn). It is the first FDA-approved treatment for Zaire ebolavirus. The 16 th annual Prix Galien USA ...

According to Inan’s team: “There is no documented production process of atezolizumab biosimilar in the literature except one ...

Tiziana Life Sciences announces discovery of new immune biomarkers in multiple sclerosis patients treated with nasal foralumab: New York Friday, January 24, 2025, 17:00 Hrs [IST] ...